Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Dermatologie (Heidelberg, Germany)|August 18, 2023
[Pemphigoid diseases in older adults]Eva Lotta Moderegger, Marie J Schmitz, Ralf J Ludwig, et al.The British Journal of Dermatology|May 27, 2024
Risk of death, major adverse cardiac events and relapse in patients with bullous pemphigoid treated with systemic or topical corticosteroidsKhalaf Kridin, Katja Bieber, Artem Vorobyev, et al.Cells|October 17, 2020
LPS-Induced Endotoxemia Evokes Epigenetic Alterations in Mitochondrial DNA That Impacts Inflammatory ResponseBjörn Koos, Eva Lotta Moderegger, Katharina Rump, et al.Frontiers in Medicine|October 24, 2025
Increased risk of deep vein thrombosis, pulmonary embolism, and all-cause mortality in chronic venous disorder: a large-scale retrospective cohort studyEva Lotta Moderegger, Sören Dräger, Sophie L Preuss, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|April 2, 2025
Dupilumab shows no elevated risk for maternal adverse pregnancy outcomes: A propensity-matched cohort studySophie L Preuß, Katja Bieber, Artem Vorobyev, et al.Acta Dermato-Venereologica|January 9, 2026
COVID-19 Infection vs Vaccination and the Risk of New-onset PsoriasisSophie L Preuß, Henning Olbrich, Katja Bieber, et al.Ebiomedicine|December 7, 2024
Biological, as opposed to classic antipsoriatic drug or apremilast, treatment mitigates the risk of death and cardiovascular disease in psoriasisKhalaf Kridin, Katja Bieber, Artem Vorobyev, et al.Pageof 1